NIVF Stock Analysis: Buy, Sell, or Hold?
NIVF - NewGenIvf Group Limited Class A ordinary shares
$0.81
-0.04 (-4.69%)
▼
5d:
-26.35%
30d:
+46.94%
90d:
-52.9%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jun 30, 2026
0d
Get Alerted When NIVF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NIVF is down 26.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NIVF is down 26.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.46
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$3.39
76.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NIVF is currently trading at $0.81, which is considered slightly low relative to its 30-day fair value range of $0.70 to $1.39. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.0) compared to its historical average (0.1). Remarkably, the market is currently pricing in an annual earnings decline of 40.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NIVF is in a downtrend. Immediate support is located at $0.67, while resistance sits at $1.35. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.36 (+5129.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NIVF is in a downtrend. Immediate support is located at $0.67, while resistance sits at $1.35. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.36 (+5129.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.70 -
$1.39
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 5129.0% below Wall St target ($42.36)
- WARNING: Recommendation downgraded due to -26.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.70 -
$1.39
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.67
Resistance Level
$1.35
Current Trend
Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.03
Wall Street Target
$42.36
(+5129.0%)
Revenue Growth (YoY)
11.9%
Profit Margin
209.0%
Valuation Discount vs History
-40.3% cheaper
PE vs Historical
0.0 vs 0.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-40.3%
(market-implied from PE analysis)
1-Year Target
$0.73
(-10%)
2-Year Target
$0.66
(-19%)
3-Year Target
$0.59
(-27%)
3-Yr Target (if PE normalizes)
(PE: 0→0)
$2.04
(+152%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 97.0%)
$1960.38
(+241893%)
Base:
(SPY PE: 0.0, Growth: 97.0%)
$2.73
(+238%)
Bear:
(PE: 0.0, Growth: 97.0%)
$2.32
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 0.01 | Current EPS (TTM): $109.44
Bull Case
$0.47
(-42%)
Analyst growth -50.0%, PE expands to 0.0
Base Case
$0.43
(-47%)
Market implied -50.0%, PE stable at 0.0
Bear Case
$0.58
(-28%)
Severe decline -20.0%, PE contracts to 0.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.0 to 0.1
Stabilization Target:
$2.80
(+245.9%)
PE Expansion Potential:
+245.9%
Share & Embed Analysis
Last updated: August 02, 2026 7:27 PM ET
Data refreshes hourly during market hours. Next update: 8:27 PM
Data refreshes hourly during market hours. Next update: 8:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NIVF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$277 | 52 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 46 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 61 BUY |
